Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients.

Abstract

Oral calcitriol is commonly used for the treatment of secondary hyperparathyroidism in patients undergoing long-term dialysis, but it has been suggested that intravenous (IV) or intraperitoneal (IP) administration enhances the therapeutic efficacy of the sterol. To examine potential mechanisms for this difference, the bioavailability of calcitriol was… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Cited By

Sort by:

PKPD modelling to predict altered disposition of 1α,25-dihydroxyvitamin D3 in mice due to dose-dependent regulation of CYP27B1 on synthesis and CYP24A1 on degradation.

Holly P Quach, Qi J Yang, Edwin C Chow, Donald E Mager, Stacie Y Hoi, K Sandy Pang
British journal of pharmacology
2015

The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial.

Justine Bacchetta, Katherine Wesseling-Perry, +5 authors Isidro B Salusky
Clinical journal of the American Society of…
2013

Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.

Katherine Wesseling-Perry, Renata C Pereira, +5 authors Isidro B Salusky
Kidney international
2011

Inter-species differences in sensitivity to the calcemic activity of the novel 1,25-dihydroxyvitamin D3 analog BXL746.

Enrico Baroni, Barbara Camisa, Daniele D'Ambrosio
Regulatory toxicology and pharmacology : RTP
2008

Intravenous calcitriol therapy in an early stage prevents parathyroid gland growth

Masatomo Taniguchi, Masanori Tokumoto, Kazuhiko Tsuruya, Hideki Hirakata, Mitsuo Iida
Nephrology, dialysis, transplantation : official…
2008

Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.

Samantha Moe, Lori D Wazny, Janet E Martin
The Canadian journal of clinical pharmacology…
2008

Pharmacokinetics of calcitriol and maxacalcitol administered into peritoneal dialysate bags in peritoneal dialysis patients.

Chieko Hamada, Kayo Hayashi, +6 authors Yasuhiko Tomino
Peritoneal dialysis international : journal of…
2005

Suppression of parathyroid hormone secretion in CAPD patients by intraperitoneal administration of Maxacalcitol

Kazutaka Murakami, Hiromi Miyachi, +9 authors Satoshi Sugiyama
Journal of Clinical and Experimental Nephrology
2004

A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.

D C Smith, C S Johnson, C C Freeman, J Muindi, J W Wilson, D L Trump
Clinical cancer research : an official journal of…
1999

CAPD/CCPD in Children

Bradley A. Warady, Richard N. Fine, +10 authors Marcela Bailez
Springer US
1998

References

Sorry, we couldn't extract any references for this paper.

Slides referencing similar topics

Diabetes and peritoneal dialysis
S. Van Laecke + 2 • Nov 03, 2017
‘New’ Technologies in Peritoneal Dialysis
Princess Alexandra Hospital + 2 • Oct 21, 2017
Cost Effectiveness Analysis on Chronic Dialysis : Comparison between Haemodialysis and Chronic Ambulatory Peritoneal Dialysis
ELSA NOVELIA + 1 • Oct 17, 2017
Show More